Skip to main content

Table 3 Predicting Duration of High-Level Psychotropic Polypharmacya

From: High-level psychotropic polypharmacy: a retrospective comparison of children in foster care to their peers on Medicaid

Variables IRRb Lower
Limit
Upper
Limit
p
Residence - Metro ref    
Non-metro 1.02 0.96 1.09 0.462
Sex - Female ref    
Male 1.04 0.97 1.11 0.268
Age Category - 12-17 years ref    
6–11 years 0.96 0.9 1.02 0.196
Race/Ethnicity – White, Non-Hispanic ref    
Black, Non-Hispanic 1.09 0.98 1.22 0.097
Hispanic 1.05 0.86 1.31 0.641
Other 0.92 0.77 1.1 0.341
Foster Care 0.96 0.88 1.05 0.319
Diagnostic Categories
 Schizophrenia and Other Psychotic Processes 0.95 0.84 1.08 0.446
 Mood Disorders Total 0.96 0.89 1.03 0.259
 Autism 1.06 0.98 1.15 0.153
 Other Neurodevelopmental Disorders 1.12 1.04 1.21 0.002
 Disruptive Behavior Disorders 1.18 1.04 1.34 0.011
 Anxiety and Trauma Related Disorders 0.95 0.89 1.01 0.118
 Impulse Control 0.9 0.81 0.99 0.030
 Sleep-Wake Disorders 0.92 0.85 1.01 0.069
  1. aamong children with at least one antipsychotic medication prescription and at least 30 days of high-level psychotropic polypharmacy; bincidence rate ratio (IRR)